Tag: standard

POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary success measure

GUELPH, Ontario, May 29, 2026 (GLOBE NEWSWIRE) -- (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class B Common Share of HPS payable on June 17, 2026, to shareholders of record at the close of business on June 10, 2026. The ex-dividend date is June 10, 2026.

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).

Plumbing contractors in 2025 across the United States face rising costs, tighter lending standards, and limited access to traditional credit. ROK Financial’s expansion of no credit check business loan programs responds to growing demand for flexible financing, offering contractors new pathways to secure working capital and sustain growth despite credit challenges.

Demand for the best HVAC business loans for bad credit in 2025 is climbing nationwide as ROK Financial expands no credit check financing programs, offering heating and cooling contractors faster access to working capital amid rising costs and tighter credit standards.

ROK Financial announces new loan pathways for pool and spa contractors heading into the 2025 season. By offering no credit check financing, fast approvals, and expanded loan ranges, the company addresses growing demand among small business owners with fair or poor credit histories. This initiative responds to the sharp rise in alternative lending searches and the increased pressure on contractors seeking reliable capital access as traditional banks tighten standards.

Contractors facing credit challenges in 2025 are fueling record demand for alternative financing, as ROK Financial expands business loan programs designed to keep projects funded and crews working nationwide.

NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Novo Nordisk A/S (NYSE:NVO), Altimmune, Inc. (NASDAQ:ALT), SelectQuote, Inc. (NYSE:SLQT) and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Demand for the best bad credit business loan options in 2025 has reached record levels as small business owners search for alternatives to traditional bank financing. With higher interest rates and stricter underwriting cutting off access to capital, ROK Financial is expanding programs that include SBA loans, lines of credit, equipment financing, and working capital solutions. This surge reflects a broader national shift toward flexible lending models that prioritize speed, transparency, and accessibility for entrepreneurs facing credit challenges across industries.

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy^® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.

Hong Kong, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BUUU Group Limited (Nasdaq: BUUU) (the “Company”), an established  meetings, incentives, conferences and exhibitions (“MICE”) solutions provider based in Hong Kong , today announced the closing of its initial public offering (the “Offering”) of 1,500,000 Class A ordinary shares (the “Class A Ordinary Shares”), at a price of $4.00 per Class A Ordinary Share (the “Offering Price”).

Ontario, California, Aug. 15, 2025 (GLOBE NEWSWIRE) --

MUCAR continues to push the boundaries of automotive technology. MUCAR, a pioneering name in automotive innovation, has unveiled its latest breakthrough: the MUCAR BT200 Max.